Open
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
Grant from National Institutes of Health
- Funder
- National Institutes of Health
- Deadline
- November 10, 2026
- Status
- Open
- Eligibility
- Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Eligible applicants must be clinical trial sites that participate in a phase 2/3 or phase 3 efficacy clinical trial (designed to provide pivotal data to support a marketing application) supported by…
- Geography
- United States
- Official source
- grants.gov
Open in GrantAuthority. The full listing, application link, requirements, attachments, program contacts and your organization's fit score are available with a free account.